HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Management of renal atrophy in hypertensive patients: experience in Lille].

AbstractINTRODUCTION:
In the absence of specific treatment, patients with renal vascular disease develop renal atrophy. This population frequently has hypertension refractory to medical treatment. The patients who may respond to revascularization or at the worst to a nephrectomy must be identified to optimize their therapeutic management.
METHODS:
We conducted an observational retrospective study of hypertensive patients with unilateral renal atrophy (renal height < 9 cm) followed at the Lille University Hospital Center from 1998 to 2006. Hypertension, renal clearance (by scintigraphy with MAG3), and hypersecretion of renin (segmental/selective venous renin samples) were studied. We subsequently classified the patients into 3 groups. Medical treatment was optimized for all.
RESULTS:
The mean follow-up period was 1.3+/-0.2 years. Eight patients were treated medically (group 1). Endovascular revascularization was used to treat the subjects for which atrophic kidney function accounted for more than 10% of their total renal function and with stenosis of the renal artery (>70%) (group 2, n=19). Those with a small nonfunctional kidney (<10% of total renal function) and hypersecretion of renin (ratio>1.5 in relation to the contralateral kidney) underwent a nephrectomy (group 3, n=8). The reduction in systolic blood pressure (SBP) was 27 mm Hg and diastolic blood pressure (DBP) 14 mm Hg for the overall study population (p < 0.001), without any significant aggravation of renal function. In group 1, the reduction in blood pressure was lower, with medical treatment alone; SBP fell by 13 mm Hg and DBP by 4mm Hg (p=ns) ; this group had the lowest initial blood pressure. In group 2, revascularization made it possible to improve SBP by 26 mm Hg and DBP by 14 mm Hg (p < 0.01) without significant impairment of renal function. Group 3 showed the most spectacular improvement in blood pressure, with SBP dropping by 40 mm Hg and DBP by 19 mm Hg (p=0.016). But it was also in this group that we observed an aggravation in the rate of glomerular filtration with a nonsignificant reduction of 12.8 mL/min, nonetheless superior to that expected according to the preoperative scintigraphy.
CONCLUSION:
The results of this work underline the importance of multidisciplinary management of patients with small ischemic kidneys. Preselection of patients in unstable clinical situations (refractory hypertension, progressive kidney failure, flash pulmonary edema) by isotopic and endocrinal renal evaluation provides a basis for deciding on treatment. The existence of a renin ratio >1.5 can identify the patients most likely to respond to nephrectomy. The reduction of renal function following nephrectomy must be considered in the discussion about treatment. The functional threshold initially defined at 10% may be lowered to 5%, to limit this postoperative reduction.
AuthorsPhilippe Marboeuf, Pascal Delsart, Christopher Hurt, Arnaud Villers, Claude Hossein-Foucher, Jean-Paul Beregi, Ghislaine Deklunder, Christian Noel, Claire Mounier-Vehier
JournalPresse medicale (Paris, France : 1983) (Presse Med) Vol. 39 Issue 4 Pg. e67-76 (Apr 2010) ISSN: 2213-0276 [Electronic] France
Vernacular TitleConduite à tenir devant une atrophie rénale chez le patient hypertendu: l'expérience lilloise.
PMID19854024 (Publication Type: Comparative Study, Journal Article)
Copyright(c) 2009 Elsevier Masson SAS. All rights reserved.
Chemical References
  • Antihypertensive Agents
  • Renin
  • Potassium
Topics
  • Antihypertensive Agents (therapeutic use)
  • Atherosclerosis (complications)
  • Atrophy
  • Blood Pressure (physiology)
  • Diabetes Mellitus, Type 2 (complications)
  • Female
  • Follow-Up Studies
  • France
  • Glomerular Filtration Rate (physiology)
  • Humans
  • Hypertension, Renovascular (physiopathology, therapy)
  • Kidney (pathology, physiopathology)
  • Male
  • Middle Aged
  • Nephrectomy
  • Postoperative Complications
  • Potassium (blood)
  • Renal Artery (surgery)
  • Renal Artery Obstruction (surgery)
  • Renal Insufficiency (physiopathology, therapy)
  • Renin (metabolism)
  • Retrospective Studies
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: